Unique lipoprotein phenotype and genotype associated with exceptional longevity.
暂无分享,去创建一个
Gil Atzmon | Clyde Schechter | Nir Barzilai | Richard Lipton | Alan R Shuldiner | Ernst J Schaefer | Suzanne Cheng | Adrienne L Cupples
[1] M. Austin. Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype , 2000, Current atherosclerosis reports.
[2] S. Yamashita,et al. Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency , 1995, European journal of clinical investigation.
[3] Revisiting the role of fat mass in the life extension induced by caloric restriction. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[4] A. Jenkins,et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. , 2003, Diabetes.
[5] W. Kraus,et al. Effects of the amount and intensity of exercise on plasma lipoproteins. , 2002, The New England journal of medicine.
[6] E. Schaefer,et al. Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients DOI 10.1194/jlr.M200037-JLR200 , 2002, Journal of Lipid Research.
[7] P. Wilson,et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. , 1994, Journal of lipid research.
[8] K. Okumura,et al. Differential effect of two common polymorphisms in the cholesteryl ester transfer protein gene on low-density lipoprotein particle size. , 2002, Atherosclerosis.
[9] J. Otvos,et al. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. , 2002, Clinical laboratory.
[10] D. Rader,et al. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. , 1995, The Journal of clinical investigation.
[11] G. Rennert,et al. Clinical Phenotype of Families with Longevity , 2004, Journal of the American Geriatrics Society.
[12] I. Gabriely,et al. Plasma HDL levels highly correlate with cognitive function in exceptional longevity. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.
[13] P. Libby. Managing the risk of atherosclerosis: the role of high-density lipoprotein. , 2001, The American journal of cardiology.
[14] A. Tall,et al. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. , 1998, Journal of lipid research.
[15] S. Yamashita,et al. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. , 1990, The Journal of clinical investigation.
[16] G. Dagenais,et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. , 1997, Circulation.
[17] Carney,et al. BRCA 1 and 2--A Genetic Link to Familial Breast and Ovarian Cancer. , 1997, Medscape women's health.
[18] R. Krauss,et al. Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein , 1999, Nature Medicine.
[19] A. Shuldiner,et al. Searching for human longevity genes: the future history of gerontology in the post-genomic era. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[20] Jukka T Salonen,et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.
[21] A. Rantala,et al. Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima‐media thickness , 2001, European journal of clinical investigation.
[22] T. Arai,et al. Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[23] D. Rader,et al. Genes influencing HDL metabolism: new perspectives and implications for atherosclerosis prevention. , 2000, Molecular medicine today.
[24] D. Falconer,et al. Introduction to Quantitative Genetics. , 1962 .
[25] J. Hokanson,et al. Complex segregation analysis of LDL peak particle diameter , 1993, Genetic epidemiology.
[26] S. Grundy,et al. Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence. , 1999, Journal of lipid research.
[27] P. Ridker,et al. Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women , 2002, Circulation.
[28] R. Krauss,et al. Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. , 1992, Clinical chemistry.
[29] M. Regan,et al. What does it take to live to 100? , 2002, Mechanisms of Ageing and Development.
[30] A. Reunanen,et al. Cholesteryl ester transfer protein gene polymorphisms are associated with carotid atherosclerosis in men , 2000, European journal of clinical investigation.
[31] M J Malloy,et al. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. , 1999, Genome research.
[32] V. Gudnason,et al. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high‐density lipoprotein in European populations , 1999, European journal of clinical investigation.
[33] J. Després,et al. HDL particle size: a marker of the gender difference in the metabolic risk profile. , 2002, Atherosclerosis.
[34] J. Boer,et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[35] Johnf . Thompson,et al. Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease Published, JLR Papers in Press, March 16, 2003. DOI 10.1194/jlr.R200018-JLR200 , 2003, Journal of Lipid Research.
[36] L. Kunkel,et al. Life-long sustained mortality advantage of siblings of centenarians , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] S. Yokoyama,et al. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: a study based on coronary angiography. , 2001, Atherosclerosis.
[38] Herman Buschke,et al. Abnormality of gait as a predictor of non-Alzheimer's dementia. , 2002, The New England journal of medicine.
[39] H. Inagaki,et al. Deficiency of choresteryl ester transfer protein and gene polymorphisms of lipoprotein lipase and hepatic lipase are not associated with longevity , 2003, Journal of Molecular Medicine.
[40] J. Sorkin,et al. Offspring of Centenarians Have a Favorable Lipid Profile , 2001, Journal of the American Geriatrics Society.
[41] T C Matise,et al. A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4 , 2001, Proceedings of the National Academy of Sciences of the United States of America.